DCF — CUMBERLAND MEDICAL CENTER
Enterprise Value: $-157.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-157.2M
Enterprise Value
$-49.3M
PV of Cash Flows
$-107.8M
PV of Terminal Value
$-173.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $86.8M | $-10.0M | -12.0% | $-13.7M | $-12.4M |
| Year 2 | $89.4M | $-9.4M | -11.0% | $-13.2M | $-10.9M |
| Year 3 | $92.1M | $-8.8M | -10.0% | $-12.7M | $-9.5M |
| Year 4 | $94.8M | $-8.6M | -9.0% | $-12.6M | $-8.6M |
| Year 5 | $97.7M | $-8.6M | -9.0% | $-12.7M | $-7.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-157.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$84.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12026188880267219
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5